High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B
- PMID: 21078947
- PMCID: PMC3019666
- DOI: 10.1128/AAC.01298-10
High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B
References
-
- Collin, S., R. Davidson, K. Ritmeijer, K. Keus, Y. Melaku, S. Kipngetich, and C. Davies. 2004. Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan. Clin. Infect. Dis. 38:612-619. - PubMed
-
- Herrero, M., G. Orfanos, D. Argaw, A. Mulugeta, P. Aparicio, F. Parreño, O. Bernal, D. Rubens, J. Pedraza, M. A. Lima, L. Flevaud, P. P. Palma, S. Bashaye, J. Alvar, and C. Bern. 2009. Natural history of a visceral leishmaniasis outbreak in highland Ethiopia. Am. J. Trop. Med. Hyg. 81:373-377. - PubMed
-
- Lyons, S., H. Veeken, and J. Long. 2003. Visceral leishmaniasis and HIV in Tigray, Ethiopia. Trop. Med. Int. Health 8:733-739. - PubMed
-
- Mueller, Y., D. B. Mbulamberi, P. Odermatt, A. Hoffmann, L. Loutan, and F. Chappuis. 2009. Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda. Trop. Med. Int. Health 14:910-917. - PubMed
-
- Oliveira, A. L., Y. M. Brustoloni, T. D. Fernandes, M. E. Dorval, R. V. Cunha, and M. N. Boia. 2009. Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil. Trop. Doct. 39:180-182. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources